We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing ...

Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE: TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners ...

Biotechnology company Veracyte (NASDAQ:VCYT) is set to replace Triumph Group (NYSE:TGI) in the S&P SmallCap 600 index prior to the market open on Tuesday, July 29. VCYT shares were +6.49% Friday ...

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society, taking place July ...

Veracyte VCYT is making solid progress in its long-term growth drivers, including in its NIGHTINGALE study for nasal swabs. The company’s Decipher franchise continues to be a strong tailwind, with ...

View the latest Veracyte Inc. (VCYT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Veracyte was formed as incubator Calderome in 2006, changed to its current moniker and raison d’etre in 2008, eventually going public in 2013, raising net proceeds of $59.2 million at $13 per share.

Veracyte's products for thyroid cancer diagnosis, namely the Afirma Genomic Sequencing Classifier and Xpression Atlas, may face constraints owing to the multifaceted nature of thyroid nodules ...

Veracyte, Inc., a global genomic diagnostics company, today announced its executive leadership succession plan, with industry veteran Marc Stapley to succeed Veracyte cofounder, Bonnie Anderson ...

Veracyte (Nasdaq: VCYT) is a global diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 3, 2021-- Veracyte, Inc. (Nasdaq: VCYT) today announced preliminary results for the fourth quarter and full year ended December 31, 2020.